Connection

NANCY P CARAWAY to Biomarkers, Tumor

This is a "connection" page, showing publications NANCY P CARAWAY has written about Biomarkers, Tumor.
Connection Strength

0.188
  1. A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis. Cancer Cytopathol. 2010 Aug 25; 118(4):175-83.
    View in: PubMed
    Score: 0.094
  2. Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior. Sci Rep. 2017 01 19; 7:40714.
    View in: PubMed
    Score: 0.037
  3. Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study. Clin Cancer Res. 2010 Aug 01; 16(15):3976-87.
    View in: PubMed
    Score: 0.023
  4. Centrosomal abnormality is common in and a potential biomarker for bladder cancer. Int J Cancer. 2003 Sep 20; 106(5):661-5.
    View in: PubMed
    Score: 0.015
  5. Fine-needle aspiration biopsy of metastatic small cell carcinoma from extrapulmonary sites. Diagn Cytopathol. 1998 Sep; 19(3):177-81.
    View in: PubMed
    Score: 0.010
  6. Metastatic ductal adenocarcinoma of the prostate: cytologic features and clinical findings. Am J Clin Pathol. 2006 Aug; 126(2):302-9.
    View in: PubMed
    Score: 0.004
  7. Surfactant protein A gene deletion and prognostics for patients with stage I non-small cell lung cancer. Clin Cancer Res. 2005 Aug 01; 11(15):5417-24.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.